Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MRK - Moore Kuehn PLLC Encourages Investors of KEM ARQL THOR and LOGM to Contact the Firm


MRK - Moore Kuehn PLLC Encourages Investors of KEM ARQL THOR and LOGM to Contact the Firm

NEW YORK, Jan. 6, 2020 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders:

KEMET Corp. (NYSE: KEM)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of KEMET in connection with the proposed sale of KEMET to Yageo. Under the terms of the proposed sale, KEMET shareholders will receive $27.20 per share.

ArQule, Inc. (NASDAQ: ARQL)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of ArQule in connection with the proposed sale of ArQule to a subsidiary of Merck & Co., Inc. (NYSE: MRK). Under the terms of the acquisition agreement, ARQL shareholders will receive $20 per share. 

Synthorx, Inc. (NASDAQ: THOR)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of Synthorx in connection with the proposed sale of Synthorx to Sanofi. Under the terms of the proposed sale, shareholders of Synthorx will receive $68.00 per share. 

LogMeIn, Inc. (NASDAQ: LOGM)

The investigation concerns possible breaches of fiduciary duty and other violations of law by the Board of LogMeIn in connection with the proposed sale of LogMeIn to affiliates of Francisco Partners and Evergreen Coast Capital.  Under the terms of the proposed sale, LogMeIn shareholders will receive $86.05 per share.

Moore Kuehn is investigating whether the Boards of the above companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process.  Moore Kuehn may ultimately seek an increased share price, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies.

Moore Kuehn encourages shareholders to contact Fletcher Moore, Esq. by email at fmoore@moorekuehn.com or telephone at (212) 709-8245.  It is free and there is no cost or obligation to you.

Moore Kuehn is a New York-based law firm with attorneys representing investors and consumers in class action litigation involving securities law violations, financial fraud, breaches of fiduciary duties, and other claims.  For additional information about Moore Kuehn, please go to http://www.moorekuehn.com/practice/new-york-securities-litigation/.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Moore Kuehn, PLLC
Fletcher Moore, Esq.
30 Wall Street, 8th Floor
New York, New York 10005
fmoore@moorekuehn.com 
(212) 709-8245

SOURCE Moore Kuehn, PLLC

Stock Information

Company Name: Merck & Company Inc.
Stock Symbol: MRK
Market: NYSE
Website: merck.com

Menu

MRK MRK Quote MRK Short MRK News MRK Articles MRK Message Board
Get MRK Alerts

News, Short Squeeze, Breakout and More Instantly...